bluebird bio Inc


Bluebird Prices New Shares At $55, Seeks To Raise $500 Million

Bluebird Bio (BLUE) priced an offering of 9.09 million shares of its common stock at $55 each, the company said late on Monday.

Polar Capital Steps Into Aurinia Pharmaceuticals Inc (AUPH), Kite Pharma Inc (KITE), But Gives bluebird bio Inc (BLUE) the Axe

A First Glance at This Hedge Fund Firm’s Strategic Q2 Moves in Biotech Sector

Thursday’s Market Insights: DryShips Inc. (DRYS), Himax Technologies, Inc. (ADR) (HIMX), bluebird bio Inc (BLUE)

Here’s a Running Tab of Updates Which We Find Most Relevant

Why These Biotech Stocks Tumbled Today: Ocular Therapeutix Inc (OCUL) and bluebird bio Inc (BLUE)

Ocular Therapeutix Inc Ocular Therapeutix Inc (NASDAQ:OCUL) investors seem to be concerned with the company’s future following the news that Antony Mattessich will succeed Dr. …

bluebird bio Inc (BLUE) Leads the Way in the Next Wave of CAR-Ts

Cowen analyst Eric Schmidt is out today with a research note on shares of bluebird bio Inc (NASDAQ:BLUE), following updated data from the company’s Phase …

Company Update (NASDAQ:BLUE): bluebird bio Inc and apceth Biopharma Announces Commercial Drug Product Manufacturing Agreement

bluebird bio Inc (NASDAQ:BLUE) and apceth Biopharma announced today that they have entered into a strategic manufacturing agreement providing for the future European …

Company Update (NASDAQ:BLUE): bluebird bio Announces First Patient Treated with LentiGlobinTM Drug Product in Phase 3 Trial of Patients with Transfusion-Dependent β-Thalassemia

bluebird bio Inc (NASDAQ: BLUE) announced treatment of the first patient in Northstar-2, the Phase 3 study of its LentiGlobin drug product in …

Roth Capital Sees Room for Optimism Following bluebird bio Inc (BLUE) ASH Read-Out

During last week’s American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego, bluebird bio Inc (NASDAQ:BLUE) provided clinical updates on …

Stock Update (NASDAQ:BLUE): Bluebird Bio Inc Announces Pricing of Public Offering of Common Stock

bluebird bio Inc (NASDAQ:BLUE) announced the pricing of an underwritten public offering of 3,289,473 shares of its common stock at a public offering …

Stock Update (NASDAQ:BLUE): Bluebird Bio Inc Announces Proposed Public Offering of Common Stock

bluebird bio Inc (NASDAQ:BLUE) announced that it has commenced an underwritten public offering of $200 million of its common stock. bluebird bio also …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts